Flatiron Health and Foundation Medicine Unveil Powerful Oncology Information Resource to Advance Precision Medicine
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161103005263/en/
"We are incredibly excited to introduce in partnership with
The clinico-genomic database includes de-identified linked clinical and genomic data from patients across a variety of tumor types allowing for a continuously updated, longitudinal view of a patient's clinical, diagnostic and therapeutic journey. The database combines anonymized, HIPAA-compliant, research-grade patient data, including diagnosis, treatment and clinical outcomes captured through Flatiron's EHR data collection platform. This data is matched with deep, highly validated molecular information, including genomic findings, variant interpretations and bio-informatic data, generated by FoundationOne®, FoundationOne® Heme and FoundationACT™.
"Foundation Medicine and Flatiron together are uniquely positioned to accomplish what many others in oncology are trying to achieve, namely, delivering a highly validated lens into rich longitudinal clinico-genomic data and analysis to advance therapeutic development," said
Expected to grow in the coming months, the clinico-genomic database is the first of several products that
ABOUT FLATIRON HEALTH
ABOUT
Cautionary Note Regarding Forward-Looking Statements for
View source version on businesswire.com: http://www.businesswire.com/news/home/20161103005263/en/
For
Media Contact:
c-dcirilli@flatiron.com
or
For
Media Contact:
dan@purecommunicationsinc.com
or
Investor Contact:
kbrown@foundationmedicine.com
Source:
News Provided by Acquire Media